MedPath

A randomised controlled trial of an online healthy relationship tool and safety decision aid for women experiencing domestic violence (I-DECIDE)

Not Applicable
Completed
Conditions
Domestic Violence
Intimate Partner Abuse
Mental Health - Depression
Registration Number
ACTRN12614001306606
Lead Sponsor
Professor Kelsey Hegarty
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
404
Inclusion Criteria

Female
-Aged between 16-50
-Residing in Australia
-Has access to a safe computer and internet connection
-Had an intimate partner do ANY of the following in the past 6 months: Made her feel afraid or unsafe; Followed or harassed her over the phone or online; Called her names, humiliated, bullied, or criticised her, or threatened her in any way; Isolated her from family or friends or restricted her behaviour in any way; Physically harmed her in any way; Forced her to do sexual things she didn't want to.
-Be willing to provide her name, a valid residential address, a valid email address and telephone number, and the first name, phone number and email address of 2 trusted contacts.

Exclusion Criteria

If women's details are unable to be validated against the Australian Electoral Roll, they will be contacted for clarification. If they still cannot be validated, they will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean self-efficacy score as measured using the General Self-Efficacy Scale (Schwarzer & Jerusalem, 1995). [Baseline, immediately after completion, and at 6 and 12 months following completion.];Mean depression score as measured by The Center for Epidemiologic Studies Depression Scale Revised (CESD-R) (Eaton, Muntaner, Smith, Tien & Ybarra, 2004)[Baseline, and at 6 and 12 months following completion.]
Secondary Outcome Measures
NameTimeMethod
Mean number of helpful actions for safety and wellbeing (item showing a checklist of possible actions)[Baseline and 6 months following completion.];Mean level of fear of partner as measured by a visual analogue scale[Baseline and 12 months following completion.];Cost-effectiveness as assessed by additional cost per point change in self-efficacy and per point change on CESD-R, where cost is measured by time spent on website and number of services used in an adapted version of an instrument from the Database of Instruments for Resource Use Management (Watson et al. 2013).[Baseline and 12 months following completion.]
© Copyright 2025. All Rights Reserved by MedPath